Invesco Ltd. 9 Meters Biopharma, Inc. Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $19,687 - $48,462	-75,722 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $903 - $1,737	-1,737 Reduced 2.24%	75,722 $45,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.33 $90 - $140	-106 Reduced 0.14%	77,459 $76,000
Q3 2021 Nov 15, 2021	BUY	$1.03 - $1.41 $21,265 - $29,110	20,646 Added 36.27%	77,565 $101,000
Q2 2021 Aug 17, 2021	BUY	$1.04 - $1.5 $59,195 - $85,378	56,919 New	56,919 $63,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.